Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.83% | 7.97% | 25.40% | -24.90% | -41.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.83% | 7.97% | 25.40% | -24.90% | -41.97% |
| Cost of Revenue | -38.89% | -54.27% | -54.85% | -49.52% | -34.75% |
| Gross Profit | 62.09% | 70.07% | 70.39% | 59.11% | 31.44% |
| SG&A Expenses | -25.00% | -29.17% | -30.68% | -21.66% | -9.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.67% | -47.46% | -48.44% | -42.79% | -28.69% |
| Operating Income | 48.10% | 57.04% | 58.42% | 47.63% | 24.51% |
| Income Before Tax | 68.78% | 56.63% | 32.49% | 5.10% | -22.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.78% | 56.63% | 32.49% | 5.10% | -22.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.78% | 56.63% | 32.49% | 5.10% | -22.44% |
| EBIT | 48.10% | 57.04% | 58.42% | 47.63% | 24.51% |
| EBITDA | 46.78% | 57.22% | 59.34% | 49.67% | 26.51% |
| EPS Basic | 73.87% | 59.79% | 34.61% | 7.29% | -20.76% |
| Normalized Basic EPS | 58.19% | 60.32% | 58.60% | 43.63% | 18.49% |
| EPS Diluted | 73.87% | 59.79% | 34.61% | 7.29% | -20.76% |
| Normalized Diluted EPS | 58.19% | 60.32% | 58.60% | 43.63% | 18.49% |
| Average Basic Shares Outstanding | 21.64% | 11.85% | 7.73% | 3.57% | 1.51% |
| Average Diluted Shares Outstanding | 21.64% | 11.85% | 7.73% | 3.57% | 1.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |